569 related articles for article (PubMed ID: 29081404)
21. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
22. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells.
Tarangelo A; Magtanong L; Bieging-Rolett KT; Li Y; Ye J; Attardi LD; Dixon SJ
Cell Rep; 2018 Jan; 22(3):569-575. PubMed ID: 29346757
[TBL] [Abstract][Full Text] [Related]
23. PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis.
Gnanapradeepan K; Indeglia A; Stieg DC; Clarke N; Shao C; Dougherty JF; Murali N; Murphy ME
J Biol Chem; 2022 Dec; 298(12):102637. PubMed ID: 36309086
[TBL] [Abstract][Full Text] [Related]
24. The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis.
Gnanapradeepan K; Basu S; Barnoud T; Budina-Kolomets A; Kung CP; Murphy ME
Front Endocrinol (Lausanne); 2018; 9():124. PubMed ID: 29695998
[TBL] [Abstract][Full Text] [Related]
25. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
26. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
Pearson M; Carbone R; Sebastiani C; Cioce M; Fagioli M; Saito S; Higashimoto Y; Appella E; Minucci S; Pandolfi PP; Pelicci PG
Nature; 2000 Jul; 406(6792):207-10. PubMed ID: 10910364
[TBL] [Abstract][Full Text] [Related]
27. Riboflavin transporter SLC52A1, a target of p53, suppresses cellular senescence by activating mitochondrial complex II.
Nagano T; Awai Y; Kuwaba S; Osumi T; Mio K; Iwasaki T; Kamada S
Mol Biol Cell; 2021 Nov; 32(21):br10. PubMed ID: 34524871
[TBL] [Abstract][Full Text] [Related]
28. Ferroptosis as a p53-mediated activity during tumour suppression.
Jiang L; Kon N; Li T; Wang SJ; Su T; Hibshoosh H; Baer R; Gu W
Nature; 2015 Apr; 520(7545):57-62. PubMed ID: 25799988
[TBL] [Abstract][Full Text] [Related]
29. p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition.
Sheikh T; Sen E
Cytokine; 2021 Apr; 140():155418. PubMed ID: 33476981
[TBL] [Abstract][Full Text] [Related]
30. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses.
Ou Y; Wang SJ; Li D; Chu B; Gu W
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6806-E6812. PubMed ID: 27698118
[TBL] [Abstract][Full Text] [Related]
31. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence.
Jiang P; Du W; Mancuso A; Wellen KE; Yang X
Nature; 2013 Jan; 493(7434):689-93. PubMed ID: 23334421
[TBL] [Abstract][Full Text] [Related]
33. Ninjurin1, a target of p53, regulates p53 expression and p53-dependent cell survival, senescence, and radiation-induced mortality.
Cho SJ; Rossi A; Jung YS; Yan W; Liu G; Zhang J; Zhang M; Chen X
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9362-7. PubMed ID: 23690620
[TBL] [Abstract][Full Text] [Related]
34. Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance.
Gibadulinova A; Pastorek M; Filipcik P; Radvak P; Csaderova L; Vojtesek B; Pastorekova S
Oncotarget; 2016 Apr; 7(16):22508-22. PubMed ID: 26967060
[TBL] [Abstract][Full Text] [Related]
35. SOCS1 in cancer: An oncogene and a tumor suppressor.
Beaurivage C; Champagne A; Tobelaim WS; Pomerleau V; Menendez A; Saucier C
Cytokine; 2016 Jun; 82():87-94. PubMed ID: 26811119
[TBL] [Abstract][Full Text] [Related]
36. Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence.
Mallette FA; Moiseeva O; Calabrese V; Mao B; Gaumont-Leclerc MF; Ferbeyre G
Ann N Y Acad Sci; 2010 Jun; 1197():142-51. PubMed ID: 20536843
[TBL] [Abstract][Full Text] [Related]
37. A gain-of-function senescence bypass screen identifies the homeobox transcription factor DLX2 as a regulator of ATM-p53 signaling.
Wang Y; Xu Q; Sack L; Kang C; Elledge SJ
Genes Dev; 2016 Feb; 30(3):293-306. PubMed ID: 26833729
[TBL] [Abstract][Full Text] [Related]
38. SOCS1 suppresses IL-1β-induced C/EBPβ expression via transcriptional regulation in human chondrocytes.
Ha YJ; Choi YS; Kang EH; Shin K; Kim TK; Song YW; Lee YJ
Exp Mol Med; 2016 Jun; 48(6):e241. PubMed ID: 27339399
[TBL] [Abstract][Full Text] [Related]
39. NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression.
Chen D; Tavana O; Chu B; Erber L; Chen Y; Baer R; Gu W
Mol Cell; 2017 Oct; 68(1):224-232.e4. PubMed ID: 28985506
[TBL] [Abstract][Full Text] [Related]
40. PML is a direct p53 target that modulates p53 effector functions.
de Stanchina E; Querido E; Narita M; Davuluri RV; Pandolfi PP; Ferbeyre G; Lowe SW
Mol Cell; 2004 Feb; 13(4):523-35. PubMed ID: 14992722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
